KPNA4 and amyotrophic lateral sclerosis: Together with previous observations limited to FTD (Solomon et al., 2018; Chou et al., 2018), our findings thus identify KPNA4 abnormalities as a common denominator and molecular signature of ALS and FTD with TDP-43 pathology.